Ranbaxy
SC throws out PIL against Ranbaxy over substandard drug issue
25 Jun 2013
Ranbaxy, the largest drug maker in India, is under attack, both because of its size and reach and the threat its generic drugs pose to the patent drugs lobby, especially in the West
European regulator fines Ranbaxy and 8 others for blocking generic drugs
19 Jun 2013
The European antitrust regulator today fined nine pharmaceutical companies including Ranbaxy a total of €146 million for blocking the supply of a cheaper anti-depressant drug to the market.
Indian doctors’ body asks DCGI to probe Ranbaxy drug quality
29 May 2013
The Indian Medical Association has asked the Drug Controller General of India to investigate the quality of drugs manufactured and sold by Ranbaxy Laboratories in India
Ranbaxy fined $500 mn by US regulator over drug safety lapses
14 May 2013
Ranbaxy Laboratories Ltd yesterday agreed to pay a record $500 million fine to settle a US civil and criminal lawsuit brought on by a whistle-blower and the US regulator
.webp)
